OpenAlex
PricingAboutJobs
Log inGet started
Work

Phase I trial of the murine monoclonal anti-GD2 antibody 14G2a in metastatic melanoma.

PubMed

Year: 1992
Type: article
Study design: Clinical Trial
Source: PubMed
Authors: M N Saleh, M B Khazaeli, R H Wheeler, E Dropcho, T Liu, M Urist, D M Miller, S Lawson, P Dixon, C H Russell
Institution: University of Alabama at Birmingham
Language: English

Topic: Monoclonal and Polyclonal Antibodies Research
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Keywords: GD2 antigen, metastatic melanoma, murine antibodies, neurotoxicity, motor neuropathy, hyponatremia, syndrome of inappropriate antidiuretic hormone secretion, human anti-mouse antibodies, plasma half-life, dose-limiting toxicity, anticancer activity
SDG: Good health and well-being

Open Access status: closed

Funder: National Institutes of Health
Award: MONOCLONAL ANTIBODIES AND OTHER TARGETING AGENTS
OpenAlex ID: W1555211613
FWCI: 3.165
Cites:
Cited by: 177
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms